Skip to main content
Clinical Trials/NCT02018354
NCT02018354
Active, not recruiting
Not Applicable

Multicenter Randomized Clinical Trial Comparing Anterior Cruciate Ligament Reconstruction With and Without Lateral Extra-articular Tenodesis in Individuals Who Are At High Risk of Graft Failure.

University of Western Ontario, Canada8 sites in 3 countries624 target enrollmentJanuary 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Anterior Cruciate Ligament Reconstruction
Sponsor
University of Western Ontario, Canada
Enrollment
624
Locations
8
Primary Endpoint
Graft Failure
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this study is to compare outcomes (failure, function, strength, range of motion and quality of life) between patients who receive the usual anterior cruciate ligament (ACL) reconstructive surgery and patients who receive anterior cruciate ligament reconstructive surgery with a lateral extra-articular tenodesis (extra tendon repair on the outside of the knee). Some studies have shown high graft failure rates (ACL re-tear) in young individuals who return to pivoting contact sports following ACL reconstruction. This study is designed to look at whether or not adding this extra tendon repair reduces the risk of graft failure in this population.

Detailed Description

This study is a pragmatic study for a parallel groups, randomized clinical trial in which 600 patients with anterior cruciate ligament insufficiency who are undergoing surgery, are randomly allocated to either ACL reconstruction alone (control) or ACL reconstruction with lateral extra-articular tenodesis (experimental). Surgeons, data collectors, and the data analyst will be blind to group allocation. The primary outcome is rate of failure. Secondary outcomes include disease specific quality of life, return to function and sport. Patients are followed for two years postoperative.

Registry
clinicaltrials.gov
Start Date
January 2014
End Date
March 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University of Western Ontario, Canada
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Graft Failure

Time Frame: 24 months

* symptomatic instability requiring revision ACL surgery * positive pivot shift or asymmetrical pivot shift greater than other contralateral side We will determine the absolute risk of graft failure in each group, calculate a relative risk (RR) and risk difference (RD) of graft failure with 95% confidence intervals around the estimate and use a Mantel Haentzel Test (random effect of surgeon) to determine the significance of the association between the addition of LET and graft failure rates. We will calculate the number needed to treat (NNT) to describe the number of patients who need to receive LET to prevent one graft failure over the first two postoperative years.

Secondary Outcomes

  • MARX Activity Rating Scale(Baseline, 3, 6, 12, 24 months)
  • Radiographic evidence of osteoarthritis(Baseline, 12, 24 months)
  • Quality-adjusted life years (QALYs) using the European Quality of Life Scale (Euro-QoL)(Baseline, 3, 6, 12, 24 months)
  • Disease-specific quality of life using the ACL Quality of Life Questionnaire (ACL-QOL)(Baseline, 3, 6, 12, 24 months)
  • Region-specific quality of life using the Knee Osteoarthritis and outcomes Score (KOOS).(Baseline, 3, 6, 12, 24 months)
  • Subjective symptoms, function and activity.(Baseline, 3, 6, 12, 24 months)
  • Passive knee extension and active-assisted knee flexion(Baseline, 3, 6, 12, 24 months)

Study Sites (8)

Loading locations...

Similar Trials